Literature DB >> 34255801

Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020.

Juan Carlos Cataño-Correa1, Jaiberth Antonio Cardona-Arias1, Jessica Paola Porras Mancilla2, Marcela Tabares García3.   

Abstract

COVID-19 represents high morbidity and mortality, its complications and lethality have increased due to bacterial superinfections. We aimed to determine the prevalence of bacterial superinfection in adults with COVID-19, hospitalized in two clinics in Medellín-Colombia during 2020, and its distribution according to sociodemographic and clinical conditions. A cross sectional study was made with 399 patients diagnosed with COVID-19 by RT-PCR. We determined the prevalence of bacterial superinfection and its factors associated with crude and adjusted prevalence ratios by a generalized linear model. The prevalence of superinfection was 49.6%, with 16 agents identified, the most frequent were Klebsiella (pneumoniae and oxytoca) and Staphylococcus aureus. In the multivariate adjustment, the variables with the strongest association with bacterial superinfection were lung disease, encephalopathy, mechanical ventilation, hospital stay, and steroid treatment. A high prevalence of bacterial superinfections, a high number of agents, and multiple associated factors were found. Among these stood out comorbidities, complications, days of hospitalization, mechanical ventilation, and steroid treatment. These results are vital to identifying priority clinical groups, improving the care of simultaneous infections with COVID-19 in people with the risk factors exposed in the population studied, and identifying bacteria of public health interest.

Entities:  

Year:  2021        PMID: 34255801     DOI: 10.1371/journal.pone.0254671

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  11 in total

1.  Coronavirus Lung Infection Impairs Host Immunity against Secondary Bacterial Infection by Promoting Lysosomal Dysfunction.

Authors:  Xiaohua Peng; Jooyoung Kim; Gayatri Gupta; Karen Agaronyan; Madeleine C Mankowski; Asawari Korde; Shervin S Takyar; Hyeon Jun Shin; Victoria Habet; Sarah Voth; Jonathon P Audia; Xinran Liu; Lin Wang; Ying Cai; Xuefei Tian; Shuta Ishibe; Min-Jong Kang; Susan Compton; Craig B Wilen; Charles S Dela Cruz; Lokesh Sharma
Journal:  J Immunol       Date:  2022-09-02       Impact factor: 5.426

2.  The Microbial Profile and Resistance Pattern of Pathogens Isolated From Long COVID Pneumonia Patients and Their Correlation to Clinical Outcome: Our Experience From a Tertiary Care Hospital.

Authors:  C Mohan Rao; Pragyan Rout; Ashwini P Pattnaik; Nipa Singh; Aarthi Rajendran; Shubhransu Patro
Journal:  Cureus       Date:  2022-03-30

3.  COVID-19 Autopsies Reveal Underreporting of SARS-CoV-2 Infection and Scarcity of Co-infections.

Authors:  Nathalie Schwab; Ronny Nienhold; Maurice Henkel; Albert Baschong; Anne Graber; Angela Frank; Nadine Mensah; Jacqueline Koike; Claudia Hernach; Melanie Sachs; Till Daun; Veronika Zsikla; Niels Willi; Tobias Junt; Kirsten D Mertz
Journal:  Front Med (Lausanne)       Date:  2022-04-14

Review 4.  Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm.

Authors:  Paulina Niedźwiedzka-Rystwej; Adam Majchrzak; Sara Kurkowska; Paulina Małkowska; Olga Sierawska; Rafał Hrynkiewicz; Miłosz Parczewski
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

Review 5.  Prospects on Repurposing a Live Attenuated Vaccine for the Control of Unrelated Infections.

Authors:  Sang-Uk Seo; Baik-Lin Seong
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

6.  RNA Sequencing in COVID-19 patients identifies neutrophil activation biomarkers as a promising diagnostic platform for infections.

Authors:  Richard Wargodsky; Philip Dela Cruz; John LaFleur; David Yamane; Justin Sungmin Kim; Ivy Benjenk; Eric Heinz; Obinna Ome Irondi; Katherine Farrar; Ian Toma; Tristan Jordan; Jennifer Goldman; Timothy A McCaffrey
Journal:  PLoS One       Date:  2022-01-26       Impact factor: 3.240

Review 7.  Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence.

Authors:  Riccardo Sarzani; Francesco Spannella; Federico Giulietti; Chiara Di Pentima; Piero Giordano; Andrea Giacometti
Journal:  Intern Emerg Med       Date:  2021-10-31       Impact factor: 3.397

8.  Tocilizumab in critically ill COVID-19 patients: An observational study.

Authors:  Muhammad Z Mushtaq; Saad B Z Mahmood; Aysha Almas; Syed Ather Wasti; Syed Ahsan Ali
Journal:  Int Immunopharmacol       Date:  2021-11-20       Impact factor: 4.932

Review 9.  Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?

Authors:  Matteo Bassetti; Laura Magnasco; Antonio Vena; Federica Portunato; Daniele Roberto Giacobbe
Journal:  Curr Opin Infect Dis       Date:  2022-04-01       Impact factor: 4.915

10.  COVID-19 Pulmonary Pathology, Ventilator-Induced Lung Injury (VILI), or Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)? Healthcare Considerations Arising From an Autopsy Case and Miny-Review.

Authors:  Roberto Scendoni; Diego Gattari; Mariano Cingolani
Journal:  Clin Pathol       Date:  2022-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.